Search hospitals > Iowa > Cedar Rapids
St. Luke's Hospital
Claim this profileCedar Rapids, Iowa 52402
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
81 reported clinical trials
1 medical researcher
Summary
St. Luke's Hospital is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. St. Luke's Hospital is involved with conducting 81 clinical trials across 96 conditions. There are 1 research doctors associated with this hospital, such as Robert J. Isaak.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage II
HER2 negative
Stage I
Top PIs
Clinical Trials running at St. Luke's Hospital
Prostate Cancer
Anal Cancer
Breast Cancer
Lung Cancer
Prostate Adenocarcinoma
Cancer
Squamous Cell Carcinoma
Anal Carcinoma
Anal Squamous Cell Carcinoma
Anal Canal Carcinoma
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at St. Luke's Hospital?
St. Luke's Hospital is a medical facility located in Cedar Rapids, Iowa. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. St. Luke's Hospital is involved with conducting 81 clinical trials across 96 conditions. There are 1 research doctors associated with this hospital, such as Robert J. Isaak.